Oregon Compounder Hit for Poor Aseptic Practices By Sam | May 5, 2020 The FDA issued a warning letter to an Oregon compounder for lax aseptic practices observed during an inspection of its facility. Source: Drug GMP Report Posted in Drug GMP Report